세계의 디지털 용량 흡입기 시장 보고서(2025년)

Digital Dose Inhalers Global Market Report 2025

US $ 4,490 ￦ 6,371,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,209,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,048,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

디지털 용량 흡입기 시장 규모는 향후 수년간 비약적인 성장이 전망됩니다. 2029년에는 CAGR 21.9%로 528억 2,000만 달러로 성장합니다. 예측 기간의 성장은 원격의료의 부상, 호흡기 질환의 유병률 증가, 복약 순응도 및 관리 개선에 대한 요구 증가, 원격의료의 부상, 소비자 인식 증가에 기인합니다. 예측 기간의 주요 동향으로는 디지털 기술 통합, 소비자 인식 및 교육, 비용 효율성, IoT 및 AI와의 통합, 원격의료의 성장 등이 있습니다.

만성 호흡기 질환의 유병률 증가는 향후 수년간 디지털 용량 흡입기 시장의 성장을 가속할 것으로 예상됩니다. 만성 호흡기 질환은 폐와 호흡기에 영향을 미치는 장기적인 질환으로 지속적인 호흡곤란을 유발하는 질환입니다. 이러한 만성 호흡기 질환 증가는 대기 오염의 심각성, 고령화, 담배 사용량 증가 등 여러 가지 요인에 기인합니다. 디지털 용량 흡입기는 천식, 만성폐쇄성폐질환(COPD) 등 환자의 복약 순응도 및 모니터링을 강화하는 데 중요한 역할을 할 수 있습니다. 예를 들어 2024년 6월 호주 정부는 2022년 데이터를 바탕으로 인구의 34%에 해당하는 약 850만 명의 호주인이 만성 호흡기 질환을 앓고 있다고 보고했습니다. 이 중 천식 환자 약 280만 명(11%), COPD 환자 약 63만 8천 명(2.5%)이 포함될 것으로 추정됩니다. 따라서 만성 호흡기 질환의 유병률 증가는 디지털 용량 흡입기 시장의 확대에 박차를 가하고 있습니다.

디지털 용량 흡입기 시장의 주요 기업은 환자의 결과와 약물 관리를 개선하기 위해 스마트 흡입기와 같은 혁신적인 제품 개발에 주력하고 있습니다. 스마트 흡입기는 약물 사용, 흡입 기술, 순응도를 모니터링하고 모바일 애플리케이션를 통해 실시간 피드백을 제공하는 센서 및 연결 기능을 갖춘 첨단 장비입니다. 예를 들어 2024년 6월 영국 헬스케어 기업 Aseptika Ltd.는 Med-Tech Innovation Expo에서 PUFFClicker3 범용 스마트 흡입기 복용량 추적기인 PUFFClicker3를 발표했습니다. 건식 분말 흡입기(DPI)를 모두 지원하며, SNOMED 코드화된 101가지 흡입기를 지원하는 최초의 흡입기 복용량 추적기입니다. 이 혁신은 서로 다른 흡입기 유형 간의 환자 전환을 용이하게 하며, 지원되는 각 흡입기 사용에 대한 그래픽 지침이 내장되어 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스 및 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 디지털 용량 흡입기 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 용도 산업의 분석
• 세계의 디지털 용량 흡입기 시장 : 성장률 분석
• 세계의 디지털 용량 흡입기 시장 실적 : 규모와 성장, 2019-2024
• 세계의 디지털 용량 흡입기 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 디지털 용량 흡입기 TAM(Total Addressable Market)

제6장 시장 세분화

• 세계의 디지털 용량 흡입기 시장 : 제품별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 정량 분무식 흡입기(MDI)
• 드라이 파우더 흡입기(DPI)
• 세계의 디지털 용량 흡입기 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 브랜드 의약품
• 제네릭 의약품
• 세계의 디지털 용량 흡입기 시장 적응증별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 천식
• 만성 폐쇄성 폐질환(COPD)
• 기타 적응증
• 세계의 디지털 용량 흡입기 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 의료기기 업계
• 병원
• 세계의 디지털 용량 흡입기 시장, 정량 분무식 흡입기(MDI)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 기존 MDI
• 스마트 MDI
• 세계의 디지털 용량 흡입기 시장, 드라이 파우더 흡입기(DPI)의 서브 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 싱글 도스 DPI
• 멀티 도스 DPI

제7장 지역별·국가별 분석

• 세계의 디지털 용량 흡입기 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 디지털 용량 흡입기 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 디지털 용량 흡입기 시장 : 경쟁 구도
• 디지털 용량 흡입기 시장 : 기업 개요
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 대기업과 혁신적 기업

• C.H. Boehringer Sohn AG & Co. KG
• AptarGroup Inc.
• Cipla Limited
• Chiesi Farmaceutici S.p.A.
• Lupin Limited
• Glenmark Pharmaceuticals Limited
• OPKO Health Inc.
• Nemera
• Sensirion AG
• Sunovion Pharmaceuticals Inc.
• MannKind Corporation
• Adherium Limited
• H&T Presspart
• Monaghan Medical Corporation
• BreatheSuite Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

• 디지털 용량 흡입기 시장 2029 : 새로운 기회를 제공하는 국가
• 디지털 용량 흡입기 시장 2029 : 새로운 기회를 제공하는 부문
• 디지털 용량 흡입기 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁의 전략

제36장 부록

KSA

영문 목차

영문목차

Digital dose inhalers (DDIs) are sophisticated inhalation devices that feature sensors and digital capabilities to monitor and track medication usage. They deliver precise doses of medication to the lungs, primarily for treating asthma and chronic obstructive pulmonary disease (COPD). DDIs also offer real-time data and reminders, which enhance medication adherence and disease management.

The main types of digital dose inhalers are metered dose inhalers (MDI) and dry powder inhalers (DPI). A metered dose inhaler (MDI) administers a specific amount of medication to the lungs in aerosol form. Medications can be branded or generic. DDIs are indicated for asthma, COPD, and other respiratory conditions. End users include the medical device industry and hospitals.

The digital dose inhalers market research report is one of a series of new reports from The Business Research Company that provides digital dose inhalers market statistics, including digital dose inhalers industry global market size, regional shares, competitors with a digital dose inhalers market share, detailed digital dose inhalers market segments, market trends and opportunities, and any further data you may need to thrive in the digital dose inhalers industry. This digital dose inhalers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital dose inhalers market size has grown exponentially in recent years. It will grow from $19.6 billion in 2024 to $23.94 billion in 2025 at a compound annual growth rate (CAGR) of 22.2%. The growth in the historic period can be attributed to rising respiratory diseases, increasing adoption of digital dose inhalers, increasing need to effectively monitor the date and time of dosing, increasing geriatric population, and increasing emphasis on customized healthcare.

The digital dose inhalers market size is expected to see exponential growth in the next few years. It will grow to $52.82 billion in 2029 at a compound annual growth rate (CAGR) of 21.9%. The growth in the forecast period can be attributed to the rise of telemedicine, increasing respiratory disease prevalence, increasing need for improved medication adherence and management, the rise of telemedicine, and rising consumer awareness. Major trends in the forecast period include integration of digital technologies, consumer awareness and education, cost-effectiveness, integration with IoT and AI, and telemedicine growth.

The increasing prevalence of chronic respiratory diseases is expected to drive the growth of the digital dose inhalers market in the coming years. Chronic respiratory diseases are long-term conditions affecting the lungs and airways, leading to ongoing breathing difficulties. This rise in chronic respiratory diseases can be attributed to several factors, including heightened air pollution, an aging population, and increased tobacco use. Digital dose inhalers play a crucial role in enhancing medication adherence and monitoring for patients with conditions like asthma and chronic obstructive pulmonary disease (COPD). For example, in June 2024, the Australian Government reported that approximately 8.5 million Australians, or 34% of the population, suffer from chronic respiratory conditions, based on 2022 data. This includes roughly 2.8 million individuals (11%) with asthma and around 638,000 people (2.5%) estimated to have COPD. Therefore, the growing prevalence of chronic respiratory diseases is fueling the expansion of the digital dose inhalers market.

Key companies in the digital dose inhalers market are concentrating on developing innovative products, such as smart inhalers, to improve patient outcomes and medication management. Smart inhalers are advanced devices equipped with sensors and connectivity features that monitor drug usage, inhalation techniques, and adherence, while providing real-time feedback through mobile applications. For instance, in June 2024, Aseptika Ltd., a UK-based healthcare company, introduced the PUFFClicker3 universal smart inhaler dose tracker at the Med-Tech Innovation Expo. The PUFFClicker3 is the first inhaler dose tracker compatible with both pressurized metered dose inhalers (pMDI) and dry powder inhalers (DPI), supporting 101 SNOMED-coded inhaler types. This innovation facilitates patient transitions between different inhaler types and includes built-in graphical instructions for using each supported inhaler.

In January 2022, Philip Morris, a US-based tobacco company, acquired Syqe Medical for $650 million. Syqe Medical, an Israeli-based medical technology firm, specializes in developing advanced inhalation devices for precise drug delivery. This acquisition aligns with Philip Morris's strategy to diversify its portfolio and enhance its position in the emerging cannabis market, highlighting the company's commitment to innovation and its proactive approach to evolving consumer health trends. AstraZeneca, a UK-based biopharmaceutical company, is also notable in the healthcare sector.

Major companies operating in the digital dose inhalers market are AstraZeneca plc, Novartis AG, 3M Company, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., C.H. Boehringer Sohn AG & Co. KG, AptarGroup Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Lupin Limited, Glenmark Pharmaceuticals Limited, OPKO Health Inc., Nemera, Sensirion AG, Sunovion Pharmaceuticals Inc., MannKind Corporation, Adherium Limited, H&T Presspart, Monaghan Medical Corporation, BreatheSuite Inc.

North America was the largest region in the digital dose inhalers market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital dose inhalers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the digital dose inhalers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital dose inhalers market consists of sales of nebulizers with digital features, digital dose-recording inhalers, and combination digital inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Dose Inhalers Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital dose inhalers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital dose inhalers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The digital dose inhalers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Metered Dose Inhaler (MDI); Dry Powder Inhaler (DPI)
• 2) By Type: Branded Medication; Generic Medication
• 3) By Indications: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Other Indications
• 4) By End User: Medical Device Industry; Hospital
• Subsegments:
• 1) By Metered Dose Inhaler (MDI): Conventional MDI; Smart MDI
• 2) By Dry Powder Inhaler (DPI): Single-Dose DPI; Multi-Dose DPI; Smart DPI
• Companies Mentioned: AstraZeneca plc; Novartis AG; 3M Company; Koninklijke Philips N.V.; Teva Pharmaceutical Industries Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Dose Inhalers Market Characteristics

3. Digital Dose Inhalers Market Trends And Strategies

4. Digital Dose Inhalers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Digital Dose Inhalers Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Dose Inhalers PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Dose Inhalers Market Growth Rate Analysis
• 5.4. Global Digital Dose Inhalers Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Dose Inhalers Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Dose Inhalers Total Addressable Market (TAM)

6. Digital Dose Inhalers Market Segmentation

• 6.1. Global Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metered Dose Inhaler (MDI)
• Dry Powder Inhaler (DPI)
• 6.2. Global Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Branded Medication
• Generic Medication
• 6.3. Global Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Other Indications
• 6.4. Global Digital Dose Inhalers Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medical Device Industry
• Hospital
• 6.5. Global Digital Dose Inhalers Market, Sub-Segmentation Of Metered Dose Inhaler (MDI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Conventional MDI
• Smart MDI
• 6.6. Global Digital Dose Inhalers Market, Sub-Segmentation Of Dry Powder Inhaler (DPI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Single-Dose DPI
• Multi-Dose DPI

7. Digital Dose Inhalers Market Regional And Country Analysis

• 7.1. Global Digital Dose Inhalers Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Dose Inhalers Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Dose Inhalers Market

• 8.1. Asia-Pacific Digital Dose Inhalers Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Dose Inhalers Market

• 9.1. China Digital Dose Inhalers Market Overview
• 9.2. China Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Dose Inhalers Market

• 10.1. India Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Dose Inhalers Market

• 11.1. Japan Digital Dose Inhalers Market Overview
• 11.2. Japan Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Dose Inhalers Market

• 12.1. Australia Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Dose Inhalers Market

• 13.1. Indonesia Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Dose Inhalers Market

• 14.1. South Korea Digital Dose Inhalers Market Overview
• 14.2. South Korea Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Dose Inhalers Market

• 15.1. Western Europe Digital Dose Inhalers Market Overview
• 15.2. Western Europe Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Dose Inhalers Market

• 16.1. UK Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Dose Inhalers Market

• 17.1. Germany Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Dose Inhalers Market

• 18.1. France Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Dose Inhalers Market

• 19.1. Italy Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Dose Inhalers Market

• 20.1. Spain Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Dose Inhalers Market

• 21.1. Eastern Europe Digital Dose Inhalers Market Overview
• 21.2. Eastern Europe Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Dose Inhalers Market

• 22.1. Russia Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Dose Inhalers Market

• 23.1. North America Digital Dose Inhalers Market Overview
• 23.2. North America Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Dose Inhalers Market

• 24.1. USA Digital Dose Inhalers Market Overview
• 24.2. USA Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Dose Inhalers Market

• 25.1. Canada Digital Dose Inhalers Market Overview
• 25.2. Canada Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Dose Inhalers Market

• 26.1. South America Digital Dose Inhalers Market Overview
• 26.2. South America Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Dose Inhalers Market

• 27.1. Brazil Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Dose Inhalers Market

• 28.1. Middle East Digital Dose Inhalers Market Overview
• 28.2. Middle East Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Dose Inhalers Market

• 29.1. Africa Digital Dose Inhalers Market Overview
• 29.2. Africa Digital Dose Inhalers Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Dose Inhalers Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Dose Inhalers Market, Segmentation By Indications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Dose Inhalers Market Competitive Landscape And Company Profiles

• 30.1. Digital Dose Inhalers Market Competitive Landscape
• 30.2. Digital Dose Inhalers Market Company Profiles
  • 30.2.1. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Koninklijke Philips N.V. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Digital Dose Inhalers Market Other Major And Innovative Companies

• 31.1. C.H. Boehringer Sohn AG & Co. KG
• 31.2. AptarGroup Inc.
• 31.3. Cipla Limited
• 31.4. Chiesi Farmaceutici S.p.A.
• 31.5. Lupin Limited
• 31.6. Glenmark Pharmaceuticals Limited
• 31.7. OPKO Health Inc.
• 31.8. Nemera
• 31.9. Sensirion AG
• 31.10. Sunovion Pharmaceuticals Inc.
• 31.11. MannKind Corporation
• 31.12. Adherium Limited
• 31.13. H&T Presspart
• 31.14. Monaghan Medical Corporation
• 31.15. BreatheSuite Inc.

32. Global Digital Dose Inhalers Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Dose Inhalers Market

34. Recent Developments In The Digital Dose Inhalers Market

35. Digital Dose Inhalers Market High Potential Countries, Segments and Strategies

• 35.1 Digital Dose Inhalers Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Dose Inhalers Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Dose Inhalers Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료